Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D01RBP
|
|||
| Drug Name |
RE-024
|
|||
| Synonyms |
fosmetpantotenate; Fosmetpantotenate; Fosmetpantotenate [USAN]; Fosmetpantotenate (USAN); 1858268-66-2; SCHEMBL15346116; CHEMBL3989938; HUWUHKIPYXWUPN-YVRVQSMLSA-N; D10934; methyl 3-((2R)-2-hydroxy-4-(((((S)-1-methoxy-1-oxopropan-2-yl)amino)(phenoxy)phosphoryl)oxy)-3,3-dimethylbutanamido)propanoate; methyl 3-((2R)-2-hydroxy-4-(((((S)-1-methoxy-1-oxopropan-2-yl)amino)(phenoxy) phosphoryl)oxy)-3,3-dimethylbutanamido)propanoate; Dimethyl 8-hydroxy-2,7,7-trimethyl-4,9-dioxo-4-phenoxy-5-oxa-3,10-diaza-4-lambda5-phosphatridecanedioate
Click to Show/Hide
|
|||
| Indication | Neurodegenerative disorder [ICD-11: 8A20-8A23; ICD-10: E83.1, G23.0] | Phase 3 | [1] | |
| Company |
Retrophin San Diego, CA
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C20H31N2O9P
|
|||
| Canonical SMILES |
CC(C(=O)OC)NP(=O)(OCC(C)(C)C(C(=O)NCCC(=O)OC)O)OC1=CC=CC=C1
|
|||
| InChI |
1S/C20H31N2O9P/c1-14(19(26)29-5)22-32(27,31-15-9-7-6-8-10-15)30-13-20(2,3)17(24)18(25)21-12-11-16(23)28-4/h6-10,14,17,24H,11-13H2,1-5H3,(H,21,25)(H,22,27)/t14-,17-,32?/m0/s1
|
|||
| InChIKey |
HUWUHKIPYXWUPN-YVRVQSMLSA-N
|
|||
| CAS Number |
CAS 1858268-66-2
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.